Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010014/S120

Oxford Partial Knee System

Biomet Manufacturing Corp · Decision date Oct 26, 2026

MEDTECHLEDGER EXPLANATIONP010014/S120

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-26 for supplement P010014/S120, titled Oxford Partial Knee System, submitted by Biomet Manufacturing Corp. The supplement is a 30-Day Notice with the recorded reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The device category is a unicompartmental, semi-constrained, metal/polymer, mobile-bearing femorotibial knee prosthesis under product code NRA, in the orthopedic specialty.

The recorded statement covers a change to the in-process inspection frequency for the tibial components of the Oxford Partial Knee System at the ZOML Shannon, Ireland manufacturing facility. This is a supplement to the existing application, not a new approval of the whole knee system. The source lists no supporting documents, so the inspection-frequency specifics and any FDA review detail beyond the recorded fields are unknown.

Whether the changed inspection frequency affects component conformance or clinical performance cannot be determined from the available record; that question remains open.

FDA approval order statement

change the in-process inspection frequency for the tibial components of the Oxford Partial Knee System at the ZOML Shannon, Ireland manufacturing facility
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Orthopedic
Decision date
Oct 26, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010014/S120
Regulatory pathway
PMA supplement
Product code
NRA
Decision code
OK30
Decision date
Oct 26, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, knee, femorotibial, unicompartmental, semi-constrained, metal/polymer, mobile bearing.

Product code
NRA
FDA device class
3

For the original device and its historical approval scope, see PMA P010014. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010014 · Original PMA

    OXFORD(TM) MENISCAL UNICOMPARTMENTAL KNEE SYSTEM

  2. P010014/S118 · Related supplement

    Oxford Partial Knee Anatomic Vivacit-E Meniscal Bearings

  3. P010014/S120 received

    Application receipt date recorded by FDA.

  4. P010014/S119 · Related supplement

    Cementless Oxford Partial Knee System

  5. P010014/S120 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P010014. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010014

Product / regulatory recordCompanyPathwayDecision dateSource
Biomet Manufacturing CorpPMA approvalApr 21, 2004FDA
Biomet Manufacturing CorpPMA supplementSep 1, 2026FDA
Biomet Manufacturing CorpPMA supplementOct 6, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biomet Manufacturing Corp

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
56 E. Bell Dr.,, P.O. Box 587, Warsaw, IN, 46581

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records